Neuroendocrine neoplasms

1 paper

Trial sponsors

Boehringer Ingelheim
Company1 trialPhase 165 people
National Cancer Institute
2 trialsPhase 3443 people
M.D. Anderson Cancer Center
2 trialsPhase 2119 people
Grupo Espanol de Tumores Neuroendocrinos
1 trialPhase 237 people

Latest

1 in 12 months

Cancer17 Aug

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement

ReviewInterventions